Videos

This program is sponsored by Eyevance Pharmaceuticals, a Santen company.

This program is sponsored by Eyevance Pharmaceuticals, a Santen company.

This program is sponsored by Eyevance Pharmaceuticals, a Santen company.

Cynthia Matossian, MD, FACS, discusses the short- and long-term treatment options for dry eye flares.

Dr Matossian explains the importance of treating dry eye flares and what can happen if they are left unchecked.

Dr Matossian elaborates on how both patients’ and physicians’ awareness of dry eyes flares affects their eyesight and how they move forward with treatment.

Cynthia Matossian, MD, FACS, provides an overview on dry eye flares, including causes, symptoms, and her experience with dry eye flare patients.

How Equinox’s new goggles might help to treat glaucoma

A panel of ophthalmologists and optometrists conclude a discussion about dry eye disease by commenting on advances occurring in the field and future expectations for managing patients.

Unique clinical trials and novel products of interest currently under investigation for the treatment of dry eye disease.

Strategies that can help eye care specialists work with patients to establish and stick to treatment plans for dry eye disease.

What to ask when triaging a patient

Orasis Pharmaceuticals drop in development for treating presbyopia